Andere Sprachen Ludwig Enterprises, Inc.

Aktien

A1JU0Z

US54973P4019

LUDG

Markt geschlossen - OTC Markets Andere Börsenplätze 21:43:50 31.05.2024			% 5 Tage	% 1. Jan.
0,21 ^USD	+11,70 %		+16,67 %	+54,98 %

20.05.	Ludwig Enterprises, Inc. meldet Ergebnis für das erste Quartal zum 31. März 2024	CI
16.04.	Ludwig Enterprises, Inc. meldet Ergebnis für das am 31. Dezember 2023 endende Geschäftsjahr	CI

Andere Sprachen

Schalten Sie alle Nachrichten frei: Seien Sie als Erster informiert und reagieren Sie vor den Märkten!

100% kostenlose Registrierung

Ludwig Enterprises, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	20.05.
Ludwig Enterprises, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	16.04.
Ludwig Enterprises Inc (OTC:LUDG) Enters Booming Artificial Intelligence Cancer Screening Market with its Non-Invasive Cancer Diagnostics Testing Kit, launching within 2024	19.03.
Ludwig Enterprises Inc. Enters Booming Artificial Intelligence Cancer Screening Market with Its Non-Invasive Cancer Diagnostics Testing Kit, Launching Within 2024	19.03.
Ludwig Enterprises Inc. (OTC:LUDG) Announces Patent Filing for Breakthrough in Identifying mRNA Genes Associated with Certain Cancers	06.03.
Ludwig Enterprises Inc. Announces Patent Filing for Breakthrough in Identifying Mrna Genes Associated with Certain Cancers	06.03.
Ludwig Enterprises, Inc. announced that it has received $0.04 million in funding	12.02.
Ludus Enterprises, Inc. Receives Continuing Review Approval on Planned Clinical Study from Advarra IRB, Columbia, MD	31.01.
Ludwig Enterprises, Inc. Announces Executive Changes	01.12.
Ludwig Enterprises, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	28.11.
Ludwig Enterprises, Inc. Appoints Scott Silverman as Chief Financial Officer	16.11.
Ludwig Enterprises, Inc. Announces Marvin S. Hausman as Chief Executive Officer	19.09.23
Ludwig Enterprises, Inc. Reports Earnings Results for the Half Year Ended June 30, 2023	18.08.23
Ludwig Enterprises, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	21.06.23
Ludwig Enterprises Announces Launches of New Nutraceutical and Strategic Marketing Plan	25.04.23
Ludwig Enterprises Launches Nugenea, Groundbreaking Nutraceutical to Fight Inflammation	12.04.23
Ludwig Enterprises, Inc. Auditor Raises 'Going Concern' Doubt	15.02.23
Ludwig Enterprises, Inc. Receives Institutional Review Board Approval on Bladder Cancer Study	03.01.23
Precision Genomics (a Ludwig Company) Will Break Major Medical News at a Presentation for LD Micro Tuesday, Oct. 25th, 2022	24.10.22
Ludwig Enterprises Files A Patent That Could Be A Major Technology Breakthrough in Healthcare	22.09.22

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Ludwig Enterprises, Inc.

Aktien

A1JU0Z

US54973P4019

LUDG

Andere Sprachen

Filter